loadpatents
name:-0.027845859527588
name:-0.022036790847778
name:-0.00068116188049316
Dickneite; Gerhard Patent Filings

Dickneite; Gerhard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dickneite; Gerhard.The latest application filed is for "modified von willebrand factor having improved half-life".

Company Profile
0.22.23
  • Dickneite; Gerhard - Marburg DE
  • Dickneite; Gerhard - Marbury DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Modified von Willebrand factor having improved half-life
Grant 11,155,601 - Moses , et al. October 26, 2
2021-10-26
Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces
Grant 9,987,328 - Zeitler , et al. June 5, 2
2018-06-05
Modified Von Willebrand Factor Having Improved Half-life
App 20180051067 - MOSES; Michael ;   et al.
2018-02-22
Compounds For Improving The Half-life Of Von Willebrand Factor
App 20180043012 - MOSES; Michael ;   et al.
2018-02-15
Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs
Grant 9,624,307 - Nahrendorf , et al. April 18, 2
2017-04-18
Factor Xii Inhibitors For The Administration With Medical Procedures Comprising Contact With Artificial Surfaces
App 20160279195 - ZEITLER; Stefan ;   et al.
2016-09-29
Use of C1-inhibitor for the treatment of secondary edema of the central nervous system
Grant 9,452,203 - Kleinschnitz , et al. September 27, 2
2016-09-27
Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces
Grant 9,352,016 - Zeitler , et al. May 31, 2
2016-05-31
von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes
Grant 9,095,564 - Dickneite , et al. August 4, 2
2015-08-04
Use Of C1-inhibitor For The Treatment Of Secondary Edema Of The Central Nervous System
App 20140371425 - Kleinschnitz; Christoph ;   et al.
2014-12-18
Von Willebrand Factor Or Factor Viii And Von Willebrand Factor For The Treatment Of Coagulopathy Induced By Inhibitors Of Thrombocytes
App 20140128325 - DICKNEITE; Gerhard ;   et al.
2014-05-08
Factor Xii Inhibitors For The Administration With Medical Procedures Comprising Contact With Artificial Surfaces
App 20140072600 - Zeitler; Stefan ;   et al.
2014-03-13
Factor Xii Inhibitors For The Treatment Of Silent Brain Ischemia And Ischemia Of Other Organs
App 20140072572 - Nahrendorf; Matthias ;   et al.
2014-03-13
von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes
Grant 8,603,979 - Dickneite , et al. December 10, 2
2013-12-10
Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates
Grant 8,580,737 - Dickneite November 12, 2
2013-11-12
Ancestral Serine Protease Coagulation Cascade Exerts A Novel Function In Early Immune Defense
App 20130177547 - Herwald; Heiko ;   et al.
2013-07-11
Synergistic therapeutic use of Prothrombin Complex Concentrates with FVIII concentrates
Grant 8,394,768 - Dickneite March 12, 2
2013-03-12
SYNERGISTIC THERAPEUTIC USE OF PROTHROMBIN COMPLEX CONCENTRATES WITH FVlll CONCENTRATES
App 20130005657 - DICKNEITE; Gerhard
2013-01-03
Interleukin-11 Fusion Proteins
App 20120258072 - Kroz; Monika ;   et al.
2012-10-11
Von Willebrand Factor Or Factor Viii And Von Willebrand Factor For The Treatment Of Coagulopathy Induced By Inhibitors Of Thrombocytes
App 20110112023 - Dickneite; Gerhard ;   et al.
2011-05-12
Interleukin-11 Fusion Proteins
App 20100143973 - Kroz; Monika ;   et al.
2010-06-10
Synergistic Therapeutic Use Of Prothrombin Complex Concentrates With Fviii Concentrates
App 20100093607 - Dickneite; Gerhard
2010-04-15
Interleukin-11 Fusion Proteins
App 20080292581 - Kroz; Monika ;   et al.
2008-11-27
Tissue glue with improved antiadhesive properties
Grant 7,276,235 - Metzner , et al. October 2, 2
2007-10-02
Use of factor XIII for stimulating the perfusion of ischemic tissue
App 20070167361 - Inbal; Aida ;   et al.
2007-07-19
Pharmaceuticals For Treating Sepsis And Septic Shock
App 20040214756 - DICKNEITE, GERHARD ;   et al.
2004-10-28
Pharmaceutical preparation for the treatment of inflammatory processes
Grant 6,790,832 - Romisch , et al. September 14, 2
2004-09-14
Tissue glue with improved antiadhesive properties
App 20030133928 - Metzner, Hubert ;   et al.
2003-07-17
Pharmaceutical preparation for the treatment of inflammatory processes
App 20020164323 - Romisch, Jurgen ;   et al.
2002-11-07
Tissue glue with improved antiadhesive properties
App 20020001584 - Metzner, Hubert ;   et al.
2002-01-03
Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
Grant 6,248,365 - Romisch , et al. June 19, 2
2001-06-19
Glycosylated prodrugs, their method of preparation and their uses
Grant 5,561,119 - Jacquesy , et al. October 1, 1
1996-10-01
Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
Grant 5,284,856 - Naik , et al. February 8, 1
1994-02-08
Amidinophenylalanine derivatives, process for their preparation, their use and compositions containing them
Grant 5,274,098 - December 28, 1
1993-12-28
1,3-thiazoles and their use as immunomodulators
Grant 4,762,848 - Scheunemann , et al. August 9, 1
1988-08-09
Use of the diterpene derivative forskolin for immunostimulation
Grant 4,578,399 - Schorlemmer , et al. March 25, 1
1986-03-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed